August 8, 2025 – Carbon Medical Technologies, Inc. (CMT), a manufacturer of implantable medical devices that utilize proprietary pyrolytic carbon coating technology, is proud to announce that both its BiomarC…
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, is among 67 stakeholder groups, including patient advocacy groups and state medtech and life sciences associations, urging the Centers for Medicare and Medicaid Services (CMS)…
WASHINGTON, DC—AdvaMed, the MedTech Association®, recently published a technical performance and safety white paper titled “Medical Imaging Device Cybersecurity: Critical Outage Situations and Response.” The white paper outlines common imaging…
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today welcomed the kickoff of the latest Medical Device User Fee Amendments (MDUFA) discussion at a public meeting at FDA headquarters. ThreeAdvaMed® senior staff members…
AdvaMed, the MedTech Association®, released the following statement today from Shaye Mandle, executive director of the organization’s Digital Health Tech division, on the announcement from the White House, CMS, and…
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, laid out medtech’s vital role in the Trump administration’s…
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, made the following comment on the collaboration between Revival Healthcare Capital and Olympus Corporation to co-found Swan EndoSurgical, Inc. to…
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, issued the following statement on the White House’s “America’s AI Action Plan”:
Washington, DC.—AdvaMed, the MedTech Association®, asked the Court of Appeals for the Third Circuit to vacate the judgment of the District Court, which if allowed to stand, would have significant…
WASHINGTON – Today, AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker on the impact the “One Big Beautiful Bill Act” will have on medtech…